Arunjyoti Bio Ventures Limited (ABVL)

BSE: ₹5.11
Stock Performance
Corporate Announcements
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the FY ended 31.03.2026

2026-05-26 18:33:32
Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for the Audited Financial Results for the Quarter and year ended 31.03.2026

2026-05-14 12:03:04
Audited Financial Statements For The Quarter And Year Ended 31.03.2026

Audited Financial Statements for the Quarter and Year ended 31.03.2026

2026-05-13 18:14:42
2026-05-12 14:50:02
2026-05-05 14:57:28
Board Meeting Intimation for Board Meeting To Be Held On 08.05.2026.

Audited Financials results for the Quarter and Year ended 31.03.2026.

2026-05-01 16:42:42
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Arunjyoti Bio Ventures Ltd 2 CIN NO. L01400TG1986PLC062463 3 Report filed for FY 2025-2026 Details of the Current block (all figures in Rs crore): 4 2 – year block period (Specify financial years)* 2025-26, 2026-27 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T – 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T – 1) which was carried forward to FY(T)}(f) = (b) – [(c) – (e)]{ If the calculated value is zero or negative, write “nil”}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 – year Block period (Specify financial years)2024-25, 2025-26 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) – (e)}#0.00 Name of the Company Secretary :-Swati JainDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Vishal Nadimpalli Designation : -CFO Date: 30/04/2026

2026-04-30 16:50:17
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyArunjyoti Bio Ventures Ltd 2CIN NO.L01400TG1986PLC062463 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 20.57 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Swati Jain Designation: Company Secretary and Compliance Officer EmailId: cenport@gmail.com Name of the Chief Financial Officer: Vishal Nadimpalli Designation: CFO EmailId: cenport@gmail.com Date: 30/04/2026 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

2026-04-30 16:44:43
Clarification In Trading Of The Shares Of The Company.

Clarification in trading of the shares of the Company.

2026-04-13 18:44:57

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 2.80 3.14 5.79 8.70 10.10 6.35 6.15 5.28 8.71 14.05 6.47 7.24
YOY Revenue Growth % - - 1113.54% 591.59% 260.78% 102.19% 6.27% -39.3% -13.73% 121.23% 5.11% 37.04%
Other Income 0.01 0.07 0.00 -0.04 0.10 0.11 0.06 0.01 0.01 0.02 0.01 0.08
Total Income 2.81 3.21 5.79 8.66 10.20 6.46 6.21 5.29 8.72 14.07 6.48 7.32
Total Expenses + 2.75 4.59 5.35 9.07 7.95 6.98 7.24 6.34 6.56 12.98 6.41 10.88
Cost of Materials Consumed 0.00 0.00 0.54 0.00 0.00 0.00 0.00 0.00 0.00 5.26 0.00 0.00
Employee Benefit Expense 0.18 1.00 1.53 1.72 1.37 2.62 2.44 2.58 2.63 0.00 2.55 3.43
Other Expenses 0.62 0.82 1.28 1.99 2.59 1.87 1.94 2.23 1.84 4.94 2.50 6.19
Operating Profit 0.05 -1.45 0.44 -0.37 2.15 -0.63 -1.09 -1.05 2.16 1.07 0.06 -3.65
OPM % 1.7% -46.3% 7.6% -4.2% 21.3% -9.9% -17.7% -20% 24.8% 7.6% 0.9% -50.4%
Profit Before Tax + 0.06 -1.39 0.44 -0.41 2.25 -0.52 -1.03 -1.04 2.17 1.09 0.07 -6.30
Tax Expense 0.01 0.01 0.72 -1.67 0.56 -0.11 -1.03 0.95 2.17 0.27 0.02 -0.90
Tax % 25% - 163.8% - 24.8% - - - 100% 25.1% 32.8% -
Profit After Tax 0.04 -1.40 -0.28 1.26 1.69 -0.41 0.00 -1.99 0.00 0.82 0.05 -5.40
EPS (Basic) 0.21 -6.63 -1.35 6.09 1.11 -0.35 -0.70 -0.11 0.13 0.04 0.00 -0.29

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 27.75 27.88 20.43 1.74 2.97 5.51
YOY Revenue Growth % -0.47% 36.48% 1077.44% -41.59% -46.11% -
Other Income 0.12 0.28 0.04 0.10 0.28 0.00
Total Income 27.87 28.17 20.47 1.83 3.25 5.51
Total Expenses + 30.28 28.51 21.77 1.56 3.17 5.42
Employee Benefit Expense 11.23 9.01 4.43 0.00 0.06 0.24
Other Expenses 13.64 8.64 4.71 0.07 0.24 0.52
Operating Profit -2.52 -0.62 -1.34 0.17 -0.20 0.09
OPM % -9.1% -2.2% -6.5% 9.9% -6.9% 1.6%
Profit Before Exceptional -2.40 -0.34 -1.30 0.27 0.08 0.09
Exceptional Items -2.74 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + -5.14 -0.34 -1.30 0.27 0.08 0.09
Tax Expense -0.60 1.48 -0.95 0.04 0.02 0.02
Tax % - - - 16.7% 26% 26%
Profit After Tax -4.54 -1.82 -0.35 0.22 0.06 0.07
EPS (Basic) -0.24 -0.10 -1.69 1.07 0.27 0.33

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 48.45 44.83 42.71 30.39 1.00 1.50
Property, Plant & Equipment 42.40 43.33 40.50 0.00 0.00 0.00
Capital Work in Progress 0.00 0.00 0.00 19.20 0.00 0.00
Non-Current Investments 0.00 1.50 0.00 0.01 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.01 0.00 0.00 0.00 0.00 0.00
Current Assets + 5.72 14.80 11.28 5.53 1.09 3.21
Inventories 0.11 2.62 2.93 0.88 0.00 0.03
Trade Receivables 3.84 3.97 2.73 0.78 0.54 1.84
Cash and Cash Equivalents 0.13 0.59 0.09 0.03 0.01 0.81
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 28.72 32.38 1.77 2.12 2.00 1.95
Equity Share Capital 18.64 18.64 2.07 2.07 2.07 2.07
Other Equity 10.08 13.74 -0.30 0.04 -0.07 -0.13
Non-Current Liabilities 12.05 21.95 44.73 32.27 0.00 0.00
Current Liabilities 13.40 5.29 7.49 1.53 0.09 2.76
Total Liabilities 25.44 27.24 52.22 33.81 0.09 2.76

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 10.36 1.45 6.31 -13.03 -0.80 -0.31
Cash from Investing Activities -4.84 -5.59 -23.29 -19.21 0.00 0.00
Cash from Financing Activities -5.99 4.65 17.04 32.27 0.00 0.00
Net Increase/Decrease in Cash -0.47 0.51 0.06 0.03 -0.80 -0.31